| 发明名称 |
SURROGATE THERAPEUTIC ENDPOINT FOR ANTI-CTLA-4 BASED IMMUNOTHERAPY OF DISEASE. |
| 摘要 |
<p>The present invention provides a method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.</p> |
| 申请公布号 |
MXPA05012832(A) |
申请公布日期 |
2006.02.13 |
| 申请号 |
MX2005PA12832 |
申请日期 |
2004.05.28 |
| 申请人 |
MEDAREX, INC. |
发明人 |
NICHOL, GEOFFREY M. |
| 分类号 |
A61K39/395;C07K16/00;C07K16/28;G01N33/574;(IPC1-7):A61K39/395 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
